[Evaluation of the Antianginal Efficacy of Ivabradine In Patients With Ischemic Heart Disease Complicated by Heart Failure].
Results of the multicenter open observational program NACHALO (evaluation of therapy in patients with combined coronary artery disease and heart failure as part of daily clinical practice), in which 569 doctors in 58 regions of the Russian Federation participated, were presented. The program included 2751 patients with ischemic heart disease, stable angina complicated by heart failure at the age from 25 to 94 years (mean age 62.6+/-9.3 years). The follow-up period was 3 months, during which two visits were carried out -after 4 weeks and a final visit-12 weeks after the initiation of therapy. Despite treatment, angina attacks (mean 6.7+/-6.1 per week), increased blood pressure (average 145.1+/-20.9/87.2+/-1.8 mm Hg) and heart rate (average 85.8+/-9.5 beats/min) were noted in patients before the inclusion in the program.